Clinical Trials Browser

Completed × Multiple Myeloma × MLN 8237 × Clear all

NCT01034553 2016-05-25

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

26 enrolled 7 charts

Multiple Myeloma